Cortes, J., André, F., Gonçalves, A., Kümmel, S., Martin, M., Schmid, P., . . . Dent, R. (2019). IMpassion132 Phase III trial: Atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer. Future oncology, 15(17), . https://doi.org/10.2217/fon-2019-0059
Chicago-Zitierstil (17. Ausg.)Cortes, Javier, et al. "IMpassion132 Phase III Trial: Atezolizumab and Chemotherapy in Early Relapsing Metastatic Triple-negative Breast Cancer." Future Oncology 15, no. 17 (2019). https://doi.org/10.2217/fon-2019-0059.
MLA-Zitierstil (9. Ausg.)Cortes, Javier, et al. "IMpassion132 Phase III Trial: Atezolizumab and Chemotherapy in Early Relapsing Metastatic Triple-negative Breast Cancer." Future Oncology, vol. 15, no. 17, 2019, https://doi.org/10.2217/fon-2019-0059.